EICHOR
● Completed
Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
Condition: Thyroid Eye Disease · TED · Sponsor: Hoffmann-La Roche
About this study
The purpose of this study is to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of subcutaneous (SC) satralizumab, a recombinant, humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, in participants with thyroid eye disease (TED).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (46)
| Thrive Health Research LLC | Beverly Hills, California, United States | — |
| UCSD Shiley Eye Center | La Jolla, California, United States | — |
| Grene Vision Group, LLC | Wichita, Kansas, United States | — |
| Johns Hopkins University | Baltimore, Maryland, United States | — |
| University of Michigan, Kellogg Eye Center | Ann Arbor, Michigan, United States | — |
| Great Lakes Eye Care | Saint Joseph, Michigan, United States | — |
| 'Northwell Health Physician Partners Ophthalmology | Great Neck, New York, United States | — |
| EyeHealth Northwest | Portland, Oregon, United States | — |
| Austin Retina Associates | Austin, Texas, United States | — |
| Eyelid Center of Utah | Salt Lake City, Utah, United States | — |
| WVU Eye Institute | Morgantown, West Virginia, United States | — |
| Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada | Buenos Aires, Argentina | — |
+ 34 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05987423